Salvage Cryo Outcomes Similar After EBRT, Brachytherapy
Study reveals comparable rates of freedom from biochemical failure at 5 years.
AUA 2015 Prostate Cancer
Early ADT for Recurrent Prostate Cancer May Hike Death Risk
This effect appears to occur mainly in men who experience recurrence when they are younger than 65 and in those with low-risk cancer.
DRE Has Limited Value for Prostate Cancer Screening
Biopsies triggered by an abnormal DRE alone were significantly less likely to detect clinically significant prostate cancer than biopsies triggered by an abnormal PSA alone.
Post-RP Outcomes Differ for Gleason 8, 9-10 Prostate Cancer
Gleason 9-10 tumors are associated with a greater risk of biochemical and clinical recurrence, but not overall survival.
Radical Prostatectomy Offers Excellent Long-Term Outcomes
Researchers report on a study in which survivors were followed up for a median of 14 years.
Surgical Margin Status Has No Effect on PCa Patient Survival
Researchers concluded that margin status is a surrogate for established risk criteria.
Elevated NLR Linked to Worse Post-RP Outcomes
Neutrophil-lymphocyte ratio could have a prognostic role in localized prostate cancer.
RALP Offers Favorable Long-Term Prostate Cancer Control
The 10-year rates of biochemical and clinical recurrence are comparable to those of open surgery.
PCa Metastasis Predictors in Active Surveillance Patients ID’d
A PSA doubling time of less than 3 years and a Gleason score of 8-10 were associated with an increased risk of metastasis.
PCa Active Surveillance Widely Used by Community Urologists
Recent study shows that 71% of prostate cancer patients with very-low-risk disease were placed on active surveillance.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in AUA 2015 Prostate Cancer
Loading... 
Loading...